the Real World Study of Orelabrutinib in the Treatment of CLL/SLL
Clinical trial NCT05975164 · UNKNOWN
Trial details
- NCT number
- NCT05975164
- Sponsor
- Shandong University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-25
- Primary completion
- 2023-12-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.